Description

Covimectin 12 mg: Ivermectin Antiparasitic Guide

Covimectin 12 contains ivermectin 12mg. It is prescribed for parasitic infections including strongyloidiasis and onchocerciasis. It works by paralysing and eliminating parasites from the body. Because ivermectin carries prescription-only status in the UK, treatment must only be started following guidance from a registered healthcare professional.

COMPOSITION

Ivermectin

Manufacturer

HAB Pharma

Expiry

Manufactured packs typically have a shelf life of 24 to 36 months. See the carton for the exact month and year of expiration.

What Is Covimectin 12?

Covimectin 12 is an oral antiparasitic medicine containing ivermectin 12mg.

Different brand names for ivermectin may be encountered at regulated UK pharmacies. This is completely normal as they contain the same active ingredient as other ivermectin-based medicines.

Established pharmaceutical formulation standards are followed in the production of Covimectin 12. Because Covimectin 12 is bioequivalent to other ivermectin medicines, the same therapeutic effect is delivered at an equivalent dose.

Covimectin 12 vs Stromectol: understanding the difference

UK patients may be more familiar with Stromectol, which is the established reference brand for ivermectin in Britain. A key clinical difference exists between the two products, and patients should understand this clearly.

Stromectol is available in 3mg tablets.

Covimectin 12 contains ivermectin 12mg per tablet. This means that 1 Ivermectin 12 tablet is equivalent to 4 Stromectol 3mg tablets in terms of ivermectin content.

This higher strength can be clinically relevant when a doctor determines that a larger dose is required. The decision regarding suitability must, in all cases, be reached by a registered healthcare professional following individual clinical assessment. Patients must never self-adjust their dose based solely on strength comparisons.

Detail	Covimectin 12	Stromectol
Active Ingredient	Ivermectin	Ivermectin
Strength Per Tablet	12mg	3mg
Manufacturer	HAB Pharma	Stromectol
Chemical Class	Macrocyclic lactone derivative	Macrocyclic lactone derivative
Mechanism of Action	GABA-mediated chloride channel opener	GABA-mediated chloride channel opener
Bioequivalence	Yes — same active ingredient	Reference brand
Therapeutic Effect	Antiparasitic — same clinical action	Antiparasitic — same clinical action
Prescription Required	Yes — POM	Yes — POM

Understanding the dosage difference: why patients may need Covimectin 12mg 

In the UK, Stromectol 3mg has historically been the better-known brand. However, some patients may require a higher total ivermectin dose depending on their body weight and the severity of their infection.

When ivermectin is prescribed, the dose is calculated at a standard rate of 200 micrograms per kilogram of body weight. For a patient weighing 60kg, this equals a total dose of 12mg, which is precisely one Covimectin 12 tablet.

For heavier patients or those requiring repeat dosing, achieving the correct total dose using 3mg Stromectol tablets would require taking multiple tablets. Covimectin 12mg offers a higher-strength option that your doctor may consider more practical in such cases.

However, this must be emphasised clearly:

• A UK-registered doctor must calculate and prescribe the correct dose for you personally
• You must never increase your dose without explicit medical guidance
• Strength does not mean suitability. Before a prescription is issued, weight, the nature of the infection, and relevant medical history are all assessed by the doctor
• A valid prescription from a regulated UK healthcare professional must be obtained before Covimectin 12 can be dispensed

How Ivermectin Works in the Body

Found in the nerve and muscle cells of parasites, glutamate-gated chloride channels are the specialised pathways targeted by ivermectin. Ivermectin binds to these channels, causing cell membrane permeability to increase. This process leads directly to paralysis of the parasite.

The paralysed parasite is then naturally destroyed and cleared from the body. Human nerve cells are not affected at therapeutic doses, which supports their safe clinical use under medical supervision.

Viral, bacterial, and fungal infections fall outside the scope of what ivermectin is able to treat. Only specific parasitic organisms are susceptible to the action of ivermectin.

When Doctors Prescribe Covimectin 12

Doctors prescribe Covimectin 12 for confirmed parasitic infections. A clinical assessment confirming ivermectin as the appropriate treatment is required before the medicine is prescribed.

Conditions it may be prescribed for include:

• Intestinal strongyloidiasis — a roundworm infection caused by Strongyloides stercoralis. It is most commonly acquired through contact with contaminated soil. — merge into one sentence and delete the duplicate soil sentence entirely
• Onchocerciasis (river blindness) — a parasitic disease transmitted by blackfly bites. It can cause serious skin damage and eye complications.
• Scabies — The mite Sarcoptes scabiei causes scabies, a skin infestation. Where topical treatments have not been effective, Covimectin 12 may be considered as a treatment option.
• Certain filarial infections — parasitic diseases caused by thread-like worms transmitted through insect bites.

Benefits of Covimectin 12

Covimectin 12 helps reduce the parasitic burden within the body. This can lead to meaningful improvements in symptoms, including abdominal discomfort, skin irritation, and fatigue.

Once a parasitic infection has been cleared, the body’s capacity to absorb nutrients effectively is restored by the treatment. This is particularly relevant in cases of intestinal infection, where parasite activity can impair digestion.

Effective treatment also reduces the risk of transmitting infection to others. Completing every dose of the prescribed course without interruption is essential to achieving this outcome reliably.

How to Take Covimectin 12

• The tablet should be taken whole and swallowed with a full glass of water. It must not be broken or altered before taking it. 
• Take on an empty stomach unless your doctor instructs otherwise
• Even when symptoms begin to improve ahead of schedule, the full prescribed course must be completed
• The correct dose is determined by your doctor after considering your body weight and the nature of your condition

Possible Side Effects

Common Side Effects

Side Effect	What to Do
Mild headache	Rest; inform your doctor if persistent
Dizziness	Avoid driving; rise slowly from seated positions
Nausea	Take with a light snack if advised by your doctor
Skin itching	Report to your doctor if it worsens

Less Common but Serious Side Effects

Side Effect	Action Required
Severe rash or blistering	Stop treatment immediately; seek urgent medical attention
Vision disturbance	Stop treatment; contact your doctor immediately
Rapid heartbeat	Inform your doctor without delay
Joint or muscle pain	Seek immediate medical advice if this develops during treatment

Seek Emergency Help Immediately If You Notice:

• Facial or throat swelling with difficulty breathing
• Seizures or loss of consciousness
• Severe skin reactions covering large areas of the body

If any of the above signs develop, 999 must be called or attendance at the nearest A&E department sought without delay.

Important Safety Advice

Liver

Patients with reduced liver function (hepatic impairment) should use Covimectin 12 with caution. Liver function may be monitored by your doctor during treatment, and dose adjustments made if clinically necessary.

Kidney

Dose adjustment is not usually required in kidney disease. However, your doctor will assess your individual condition before prescribing.

Alcohol

Dizziness risk can be heightened by alcohol, which is why its consumption should be avoided for the full duration of treatment.Driving

Covimectin 12 may cause dizziness or blurred vision in some patients. Until the effects of this medicine on concentration and alertness are fully understood, driving and operating heavy machinery should be avoided.

Pregnancy

Covimectin 12 is not recommended during pregnancy unless clearly necessary. Direct guidance from a registered medical professional is required throughout the use of this medicine.

Breastfeeding

Ivermectin has been reported to pass into breast milk in trace amounts. A thorough assessment of risks versus benefits must be completed by your doctor before use during breastfeeding.

Drug Interactions

All medicines currently being taken — prescribed, over-the-counter, and herbal — must be disclosed to your doctor before Covimectin 12 is started.

Medicines known to interact with ivermectin include warfarin (a blood-thinning medicine) and certain anticonvulsants. Your pharmacist can carry out a medicines review to identify potential interactions.

Reporting Side Effects in the UK

Side effects experienced whilst taking Covimectin 12 can be reported to UK regulators through the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk. Through this scheme, the safety of medicines in active clinical use is monitored by UK regulators, allowing any emerging risks to be identified promptly.

Missed Dose and Overdose Guidance

Missed dose

As soon as a missed dose is remembered, it should be taken. When the next dose is approaching, the missed one should simply be omitted. A missed dose must never be compensated for by taking two doses at once.

Overdose

Should an overdose occur, 999 must be called or the nearest A&E department attended without delay. Emergency medical attention is required immediately.

Storage and Handling

• Storage below 25°C is required for Covimectin 12. It must also be kept away from direct sunlight and sources of heat.
• Retaining it in the original packaging helps protect the contents from moisture.
• Children must never be able to access, see, or reach this medicine.
• The expiry date on the packaging must be checked before each dose is taken. The medicine must not be used once this date has elapsed. 
• Unused medicine should be returned to a local pharmacy rather than disposed of in household waste.

Responsible Access to Treatment in the UK

Covimectin 12 holds prescription-only (POM) status in the UK. Before Covimectin 12 can be dispensed, a valid prescription from a registered healthcare professional must be in place. Obtaining it without a prescription is not permitted. Treatment must not be started or altered without their guidance.

FAQs

Q: What is Covimectin 12 used for?

A: Covimectin 12 contains ivermectin 12mg. Strongyloidiasis and onchocerciasis are among the parasitic infections for which this medicine is an established treatment.

Q: What are the main side effects of ivermectin?

A: Dizziness, nausea, headache, and skin itching are among the side effects most commonly reported by patients taking this medicine. Serious reactions such as severe rash or vision disturbance require urgent medical attention. Always consult your doctor promptly.

Conclusion

Covimectin 12mg represents a well-established option for the treatment of parasitic infections. Its clinical utility is supported by a favourable balance of cost, effectiveness, and tolerability. Whether it is the right choice for you is a decision that should be reached with your doctor or registered pharmacist.

References

• NHS. Parasitic infections: treatment guidance. www.nhs.uk
• MHRA. Ivermectin: product information and safety. www.mhra.gov.uk

Medical Disclaimer

This article is for informational purposes only and does not replace professional medical advice. Always consult a registered healthcare professional before starting or changing any treatment. If you experience a medical emergency, call 999 or attend your nearest A&E department immediately.